{"id":3911,"date":"2016-09-27T07:13:55","date_gmt":"2016-09-27T05:13:55","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/"},"modified":"2020-06-26T14:30:02","modified_gmt":"2020-06-26T12:30:02","slug":"nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/","title":{"rendered":"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI"},"content":{"rendered":"
\n

<\/strong><\/span><\/p>\n<\/div>\n

ALMI har beslutat att st\u00f6dja Nanexa med ett tillv\u00e4xtl\u00e5n om 5,7 MSEK. Detta med syfte att m\u00f6jligg\u00f6ra investeringar i utrustning f\u00f6r att skala upp processen f\u00f6r PharmaShell\u00aesamt annan utrustning f\u00f6r att effektivisera utvecklingsarbetet.<\/span><\/p>\n

I de investeringar som detta l\u00e5n m\u00f6jligg\u00f6r ing\u00e5r framf\u00f6rallt investering i en st\u00f6rre och mer avancerad ALD-reaktor (ALD st\u00e5r f\u00f6r Atomic Layer Deposition) d\u00e4r Nanexa kommer kunna p\u00e5visa och dokumentera uppskalning av PharmaShell\u00ae-processen, vilket \u00e4r viktigt f\u00f6r de stora l\u00e4kemedelsbolagen. Den nya reaktorn kommer vara k\u00e4rnan i Nanexas pilotskaleanl\u00e4ggning d\u00e4r pr\u00f6vningsmaterial f\u00f6r kliniska studier kan tillverkas, n\u00e5got som bolaget bed\u00f6mer kommer att efterfr\u00e5gas av Nanexas samarbetspartners fram\u00f6ver. Dessutom ing\u00e5r att investera i ytterligare analysutrustning f\u00f6r att inom bolaget kunna utf\u00f6ra fler och snabbare analyser f\u00f6r att effektivisera arbetet. Allt detta m\u00f6jligg\u00f6rs genom tillv\u00e4xtl\u00e5net fr\u00e5n Almi.<\/span><\/p>\n

\u201dTillv\u00e4xtl\u00e5net ger Nanexa m\u00f6jlighet att ytterligare accelerera utvecklingen och d\u00e4rigenom p\u00e5skynda framtagandet av n\u00f6dv\u00e4ndig data f\u00f6r framtida kommersiella avtal\u201d, s\u00e4ger David Westberg, VD f\u00f6r Nanexa.<\/span><\/p>\n

Beviljat l\u00e5n \u00e4r p\u00e5 5,7 MSEK och \u00e4r amorteringsfritt under 30 m\u00e5nader och har en l\u00f6ptid p\u00e5 8 \u00e5r. L\u00e5net omfattas av en garanti inom ramen f\u00f6r det europeiska instrumentet InnovFin \u2013EU som en del av Horizon 2020.<\/span><\/p>\n

F\u00f6r mer information kontakta:<\/span><\/p>\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0<\/span><\/p>\n

?Telefon: 0709 -42 83 03?<\/span><\/p>\n

E-post:\u00a0david.westberg@nanexa.se<\/span><\/p>\n

www.nanexa.se<\/a><\/span><\/p>\n

Om Nanexa AB (publ)<\/span><\/p>\n

Nanexa AB \u00e4r ett h\u00f6gteknologiskt forskningsf\u00f6retag som utvecklar och marknadsf\u00f6r produkter inom nanoteknologi. Bolagets fokus ligger p\u00e5 PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal omr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca Uppsala universitet och Karolinska Institutet.<\/span><\/p>\n

\n

Bifogade filer<\/strong><\/p>\n\n

<\/a><\/p>\n<\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n

ALMI har beslutat att st\u00f6dja Nanexa med ett tillv\u00e4xtl\u00e5n om 5,7 MSEK. Detta med syfte att m\u00f6jligg\u00f6ra investeringar i utrustning f\u00f6r att skala upp processen f\u00f6r PharmaShell\u00aesamt annan utrustning f\u00f6r att effektivisera utvecklingsarbetet.<\/p>\n

L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3911","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"ALMI har beslutat att st\u00f6dja Nanexa med ett tillv\u00e4xtl\u00e5n om 5,7 MSEK. Detta med syfte att m\u00f6jligg\u00f6ra investeringar i utrustning f\u00f6r att skala upp processen f\u00f6r PharmaShell\u00aesamt annan utrustning f\u00f6r att effektivisera utvecklingsarbetet.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T12:30:02+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\\\/\",\"name\":\"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2016-09-27T05:13:55+00:00\",\"dateModified\":\"2020-06-26T12:30:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI - Nanexa AB","og_description":"ALMI har beslutat att st\u00f6dja Nanexa med ett tillv\u00e4xtl\u00e5n om 5,7 MSEK. Detta med syfte att m\u00f6jligg\u00f6ra investeringar i utrustning f\u00f6r att skala upp processen f\u00f6r PharmaShell\u00aesamt annan utrustning f\u00f6r att effektivisera utvecklingsarbetet.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/","og_site_name":"Nanexa AB","article_modified_time":"2020-06-26T12:30:02+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/","name":"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2016-09-27T05:13:55+00:00","dateModified":"2020-06-26T12:30:02+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-publ-beviljas-tillvaxtlan-om-57-msek-fran-almi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa AB (publ) beviljas tillv\u00e4xtl\u00e5n om 5,7 MSEK fr\u00e5n ALMI"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}